Scientific American's Katharine Harmon looks into the challenges facing the consumer genetic testing industry, which include interpreting the data, an unclear regulatory situation, and a lack of customers. Harmon says that despite these drawbacks, that many in the industry are optimistic. "Once the numbers [of genomes] are high enough," says John Boyce, co-founder of Delphi Bio who is also involved with GnuBio, "we should have the power to see deeper into the genome and find the predictive biomarkers."
Premium Trial: